Polaris Venture Management Co V’s aTyr Pharma ATYR Stock Holding History

Polaris Venture Management Co V’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.19M	Hold	130,572	–	–	8.42%	3
2021 Q2	$637K	Hold	130,572	–	–	1.02%	4
2021 Q1	$581K	Hold	130,572	–	–	0.75%	5
2020 Q4	$507K	Hold	130,572	–	–	0.66%	5
2020 Q3	$422K	Hold	130,572	–	–	0.7%	8
2020 Q2	$580K	Buy	130,572 +1	+0%	+$4	0.45%	8
2020 Q1	$366K	Hold	130,571	–	–	0.33%	8
2019 Q4	$544K	Hold	130,571	–	–	0.4%	8
2019 Q3	$457K	Buy	130,571 +121,244	+1,300%	+$447K	0.26%	9
2019 Q2	$670K	Sell	9,327 -121,244	-93%	-$823K	0.53%	10
2019 Q1	$1.01M	Hold	130,571	–	–	0.85%	10
2018 Q4	$906K	Hold	130,571	–	–	0.97%	8
2018 Q3	$1.49M	Hold	130,571	–	–	0.74%	10
2018 Q2	$1.66M	Hold	130,571	–	–	0.91%	10
2018 Q1	$4.84M	Hold	130,571	–	–	2.76%	7
2017 Q4	$6.4M	Hold	130,571	–	–	5.64%	6
2017 Q3	$9.23M	Hold	130,571	–	–	7.94%	4
2017 Q2	$6.21M	Hold	130,571	–	–	6.43%	6
2017 Q1	$6.4M	Hold	130,571	–	–	6.85%	7
2016 Q4	$3.93M	Hold	130,571	–	–	4.66%	7
2016 Q3	$5.81M	Hold	130,571	–	–	6.14%	8
2016 Q2	$5.08M	Hold	130,571	–	–	5.46%	7
2016 Q1	$7.2M	Hold	130,571	–	–	6.88%	7
2015 Q4	$18M	Hold	130,571	–	–	14.12%	3
2015 Q3	$18.8M	Hold	130,571	–	–	12.78%	2
2015 Q2	$33.9M	Buy	+130,571	New	+$40.5M	15.1%	3

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Polaris Venture Management Co V's ATYR Position: Q3 2021 in Review

Polaris Venture Management Co V held its aTyr Pharma (ATYR) position steady in Q3 2021 at 130,572 shares worth $1.19M. The position accounts for 8.42% of the portfolio, ranked #3.

Polaris Venture Management Co V first reported a position in ATYR in Q2 2015 and has held it in 26 quarters since. The position peaked at $33.9M in Q2 2015. 42 funds tracked by Wall St. Rank hold ATYR as of Q3 2021.

Polaris Venture Management Co V held 130,572 shares of aTyr Pharma worth $1.19M as of Q3 2021.
Polaris Venture Management Co V left its aTyr Pharma share count unchanged in Q3 2021.
aTyr Pharma made up 8.42% of Polaris Venture Management Co V's portfolio in Q3 2021, its #3 holding.
Polaris Venture Management Co V first reported a position in aTyr Pharma in Q2 2015 and has held it in 26 quarters since.
Polaris Venture Management Co V's aTyr Pharma position peaked at $33.9M in Q2 2015.
42 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2021.

Based on Polaris Venture Management Co V's 13F filing for Q3 2021, filed 12 Nov 2021.